These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 33687691)

  • 1. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine.
    Carli G; Nichele I; Ruggeri M; Barra S; Tosetto A
    Intern Emerg Med; 2021 Apr; 16(3):803-804. PubMed ID: 33687691
    [No Abstract]   [Full Text] [Related]  

  • 2. Internal Jugular Vein Thrombus in Coronavirus Disease (COVID-19).
    Koritala T; Johnson DW
    AJR Am J Roentgenol; 2021 Jul; 217(1):257. PubMed ID: 33566679
    [No Abstract]   [Full Text] [Related]  

  • 3. Unusual case of venous thrombosis.
    Jones O; Gooding R
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28314810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apixaban in the treatment of venous thrombosis associated with permanent pacemaker implantation].
    Carrizo S; Figueroa JA; Vivero A
    Medicina (B Aires); 2015; 75(6):410-2. PubMed ID: 26707667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban and rivaroxaban in patients with cerebral venous thrombosis.
    Covut F; Kewan T; Perez O; Flores M; Haddad A; Daw H
    Thromb Res; 2019 Jan; 173():77-78. PubMed ID: 30481600
    [No Abstract]   [Full Text] [Related]  

  • 6. Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study.
    Kim SA; Choi GH; Lee JY; Jang ES; Lee JO; Kim JW; Jeong SH; Bang SM
    Thromb Res; 2024 May; 237():181-183. PubMed ID: 38626593
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.
    de Barros E Silva PGM; Macedo AVS; Bronhara B; Damiani LP; Mazza Barbosa L; Lopes NR; Suiama MA; Antunes MO; Gonçalves MR; Gebara OCE; de Aquino Martins P; Ribeiro MG; de Moura Xavier de Moraes JB; Aguiar VCR; Cavalcanti AB; Rosa RG; Berwanger O; Veiga VC; Azevedo LCP; Ramacciotti E; Granger CB; Alexander JH; Avezum A; Lopes RD;
    Circulation; 2024 Jul; 150(1):82-85. PubMed ID: 38950107
    [No Abstract]   [Full Text] [Related]  

  • 9. Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism. Warfarin remains the standard therapy.
    Prescrire Int; 2015 Sep; 24(163):206. PubMed ID: 26417627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and Thrombosis: More Than Just by Chance.
    Shah K
    Am J Med Sci; 2020 Dec; 360(6):733-734. PubMed ID: 32747007
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology.
    Xiao H; Meng X; Songtao Li ; Li Z; Fang S; Wang Y; Li J; Tang J; Ma L
    Biomaterials; 2024 Dec; 311():122670. PubMed ID: 38941685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
    Mochizuki T; Ikari K; Yano K; Hiroshima R; Ishibashi M; Okazaki K
    Mod Rheumatol; 2019 Jul; 29(4):682-686. PubMed ID: 30041559
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
    Arachchillage DR; Besser M; Maclean R; Baglin T; van Veen JJ
    Thromb Res; 2016 Jul; 143():137-40. PubMed ID: 27244105
    [No Abstract]   [Full Text] [Related]  

  • 15. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    Pavord S; Hunt BJ; Horner D; Bewley S; Karpusheff J;
    BMJ; 2021 Oct; 375():n2195. PubMed ID: 34598931
    [No Abstract]   [Full Text] [Related]  

  • 18. Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
    Overstad S; Tjonnfjord E; Garabet L; Fronas S; Bergan J; Aballi S; Ghanima W
    Thromb Res; 2020 Oct; 194():116-118. PubMed ID: 32788102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young Woman With Neck Pain.
    Gehrz JA; Gutweiler A; Goldenberg WD
    Ann Emerg Med; 2021 Feb; 77(2):e73-e74. PubMed ID: 33487329
    [No Abstract]   [Full Text] [Related]  

  • 20. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
    Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.